课题基金 / 基金详情

Functional consequences of NFATc1 sumoylation on lymphocyte activation, differentiation and tolerance

Functional consequences of NFATc1 sumoylation on lymphocyte activation, differentiation and tolerance
NFATc1 sumoylation 对淋巴细胞活化、分化和耐受性的功能影响
批准号:
71924695
负责人:
Professorin Dr. Friederike Berberich-Siebelt
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2014-12-31

项目摘要

项目成果

Professorin Dr. Friederike Berberich-Siebelt的其他基金

相似基金

相关文献

中文摘要
翻译
NFATc 1是“活化T细胞核因子”家族的转录因子,其在淋巴细胞中抗原受体介导的基因调控中起重要作用。NFATc 1以多种同种型合成,包括独特的高度诱导型和强效反式激活短NFATc 1/A。相反,组成型表达的长亚型NFATc 1/C跨越一个额外的C末端肽,我们证明了SUMO 1的修饰引起NFAT靶基因亚组的反式阻遏。虽然一些效应细胞因子的表达甚至在类小泛素化后增强,但白细胞介素-2(IL 2)和抗凋亡Bcl 2a 1被抑制。在机制上,类小泛素化的NFATc 1/C募集HDAC,导致组蛋白的脱乙酰化。此外,类小泛素化的NFATc 1/C与Blimp 1相互作用,Blimp 1是T细胞中IL 2和B细胞中Bcl 2a 1的既定阻遏物。为了阐明NFATc 1类小泛素化在体内的重要性,我们产生了一个复杂的NFATc 1突变的小鼠。在单个小鼠中,小泛素化缺陷型NFATc 1/C和-在与cre-deleter菌株杂交后-额外的C-末端肽缺陷型小鼠的组合使我们能够首先在体内引发NFATc 1小泛素化的功能作用,然后评估额外的C-末端是否仅通过小泛素化发挥功能。第一个实验揭示了增强的IL 2在体内的生产,增加生殖中心B细胞和伴随的免疫球蛋白的生产后免疫。有趣的是,仅仅是NFATc 1/C类小泛素化的缺乏保护小鼠免受实验性自身免疫性脑脊髓炎。
英文摘要
NFATc1 is a transcription factor of the family of “Nuclear Factors of Activated T cells” which plays an essential role in antigen receptor-mediated gene regulation in lymphoid cells. NFATc1 is synthesised in multiple isoforms including the distinguished highly inducible and potently transactivating short NFATc1/A. On the contrary, the constitutively expressed long isoform NFATc1/C spans an extra Cterminal peptide, for which we demonstrated modification by SUMO1 causing transrepression on a subgroup of NFAT target genes. While expression of some effector cytokines is even enhanced upon sumoylation, interleukin-2 (Il2) and the antiapoptotic Bcl2a1 are repressed. Mechanistically, sumoylated NFATc1/C recruits HDACs leading to deacetylation of histones. Moreover, sumoylated NFATc1/C interacts with Blimp1, an established repressor for Il2 in T cells and Bcl2a1 in B cells. To elucidate the importance of NFATc1 sumoylation in vivo, we generated a sophisticated NFATc1-mutated mouse. The combination, in a single mouse, of both a sumoylation-deficient NFATc1/C and - upon crossing with a cre-deleter strain - an extra C-terminal peptide-deficient mouse puts us in the position to 1st elicit the functional role of NFATc1 sumoylation in vivo and 2nd evaluate if the extra C-terminus functions solely through sumoylation. First experiments revealed enhanced Il2 production in vivo, an increase in germinal centre B cells and concomitant immunoglobulin production upon immunization. Intriguingly, solely the absence of NFATc1/C sumoylation protects mice from Experimental Autoimmune Encephalomyelitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Posttranslationelle Modifikationen und die Bildung von NFAT-Multiprotein-Komplexen bei der Apoptose-Regulation lymphoider Zellen
  • 批准号:
    32644728
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professorin Dr. Friederike Berberich-Siebelt
  • 依托单位:
Rolle von C/EBPß und C/EBP-regulierenden nukleären "Shuttle"-Kinasen bei der Differenzierung von T-Zellen
  • 批准号:
    5300432
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2000
  • 负责人:
    Professorin Dr. Friederike Berberich-Siebelt
  • 依托单位:
The overall role of NFAT in development and function of Tcon and Treg
  • 批准号:
    456615866
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professorin Dr. Friederike Berberich-Siebelt
  • 依托单位:
Role of NFAT signaling in immune responses and protection against CMV
  • 批准号:
    421448670
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professorin Dr. Friederike Berberich-Siebelt
  • 依托单位:
国内基金
海外基金
Exposing Verifiable Consequences of the Emergence of Mass
  • 批准号:
    12135007
  • 项目类别:
    重点项目
  • 资助金额:
    313万元
  • 批准年份:
    2021
  • 负责人:
    Craig Darrian Roberts
  • 依托单位:
Accretion variability and its consequences: from protostars to planet-forming disks
  • 批准号:
    12173003
  • 项目类别:
    面上项目
  • 资助金额:
    60万元
  • 批准年份:
    2021
  • 负责人:
    沈雷歌
  • 依托单位:
Consequences of MALT1 mutation for B cell tolerance
  • 批准号:
    32100719
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    James Qun Wang
  • 依托单位: